Gilead Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,179	7,564	9,991	6,085	5,412	5,338
Short-Term Investments	-	68	-	1,179	973	1,182
Cash & Short-Term Investments	3,179	7,632	9,991	7,264	6,385	6,520
Cash Growth	-39.02%	-23.61%	37.54%	13.77%	-2.07%	-11.99%
Accounts Receivable	5,055	4,913	4,420	4,660	4,777	4,493
Inventory	1,953	1,774	1,710	1,787	1,507	1,618
Other Current Assets	3,759	4,024	3,052	2,374	1,774	2,141
Total Current Assets	13,945	18,342	19,173	16,085	14,443	14,772
Net Property, Plant & Equipment	5,833	5,606	5,414	5,317	5,475	5,121
Other Intangible Assets	14,032	16,978	19,948	26,454	28,894	33,455
Goodwill	8,314	8,314	8,314	8,314	8,314	8,332
Long-Term Investments	-	2,974	-	1,163	1,245	1,309
Other Long-Term Assets	7,238	6,809	6,147	4,792	4,800	4,963
Total Assets	49,362	59,023	58,995	62,125	63,171	67,952
Accounts Payable	674	715	833	550	905	705
Accrued Expenses	4,233	4,337	3,892	3,802	3,479	3,244
Current Portion of Long-Term Debt	2,414	2,807	1,815	1,798	2,273	1,516
Other Current Liabilities	3,699	3,953	5,464	5,130	4,580	6,145
Total Current Liabilities	11,020	11,813	12,004	11,280	11,237	11,610
Long-Term Debt	23,832	22,129	24,896	23,189	22,957	25,179
Other Long-Term Liabilities	2,766	2,463	2,849	4,907	7,768	10,099
Total Long-Term Liabilities	26,598	24,592	27,745	28,096	30,725	35,278
Total Liabilities	37,618	36,405	39,749	39,376	41,962	46,888
Common Stock	1	1	1	1	1	1
Additional Paid-in Capital	9,532	8,932	7,700	6,500	5,550	4,661
Accumulated Other Comprehensive Income	95	39	132	28	2	83
Retained Earnings	2,200	13,730	11,497	16,304	15,687	16,324
Total Common Shareholders' Equity	11,829	22,703	19,330	22,833	21,240	21,069
Minority Interest	-84	-84	-84	-84	-31	-5
Shareholders' Equity	11,744	22,618	19,246	22,749	21,209	21,064
Total Liabilities & Equity	49,362	59,023	58,995	62,125	63,171	67,952
Total Debt	26,246	24,936	26,711	24,987	25,230	26,695
Net Cash (Debt)	-23,067	-17,304	-16,720	-17,723	-18,845	-20,175
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-18.44	-13.79	-13.32	-14.09	-14.93	-15.99
Book Value	11,829	22,703	19,330	22,833	21,240	21,069
Book Value Per Share	9.46	18.09	15.40	18.15	16.83	16.69
Tangible Book Value	-10,517	-2,589	-8,932	-11,935	-15,968	-20,718
Tangible Book Value Per Share	-8.41	-2.06	-7.12	-9.49	-12.65	-16.42

SEC Filings: 10-K · 10-Q